-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $50

Benzinga·12/04/2025 18:09:21
Listen to the news
Oppenheimer analyst Justin Kim maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $44 to $50.